You Searched For "pfizer biontech" and got 20 results
Sort By:
Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine
The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…
Matthew Fox
Pfizer and AstraZeneca COVID-19 vaccines less effective against Delta variant, says a Oxford University study
Two doses of either vaccine still provided at least the same level of protection as having had …
PTI
Pfizer and BioNTech have started testing an Omicron-specific COVID-19 vaccine for adults
The study will measure the safety and effectiveness of a vaccine tailored to the Omicron variant in…
Jake Epstein
Pfizer, BioNTech ask FDA to authorize two-dose COVID-19 vaccine for children under 5
In a Tuesday press release, the FDA said the agency pushed Pfizer and BioNTech to submit the applic…
Erin Snodgrass
BioNTech has already started developing a new Omicron version of its COVID-19 vaccine
The German biotech, which makes COVID-19 vaccines with Pfizer, said Monday it doesn't want to "wast…
Mary Hanbury
Pfizer soars 11% on strong results from COVID-19 pill study, while Moderna and Merck tumble
Pfizer plans to seek the Food and Drug Administration's OK this month for the pill, with doses pote…
Phil Rosen
The FDA's expert panel just gave a thumbs-up for Pfizer's COVID-19 vaccine in younger children, clearing the path for authorization in a matter of days
Younger children between 5 and 11 years old could start getting the Pfizer-BioNTech coronavirus vac…
Andrew Dunn
The FDA is weighing in on whether to authorize Pfizer's COVID-19 vaccine in younger kids
The data comes as the Food and Drug Administration enters the final stages of reviewing Pfizer's ap…
Andrew Dunn
FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19
The hope is that booster shots will help protect those most at risk as the pandemic continues to ra…
Andrew Dunn
Pfizer climbs after boosting its 2021 COVID-19 vaccine sales forecast by 73%
The company now expects vaccine revenues of around $26 billion, 73% higher than initially projected.
Isabelle Lee
The Pfizer vaccine's full name is Comirnaty - a hectic mashup of COVID-19, community, immunity, and mRNA
Pfizer's COVID-19 vaccine got full FDA approval on Monday, including of its official name, Comirnat…
Dr. Catherine Schuster-Bruce
Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress
Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…
Ethan Wu
Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval
The companies aim to apply for emergency-use authorization within days. If approved, the vaccine co…
Ben Winck
Moderna was the most-bought stock for retail traders in the week leading up to its 16% single-day plunge
Wall Street analysts appear less keen than retail traders on vaccine makers such as Moderna, after …
Harry Robertson
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead
Vaccine demand is likely to persist well into next year, the company said, with more than a billion…
Ethan Wu
FDA expected to approve Pfizer-BioNTech's COVID-19 vaccine by early September: NYT
The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to …
Azmi Haroun
Canada approves Pfizer-BioNTech COVID-19 vaccine for 12-15 year olds
Canada announced its approval of administering the Pfizer-BioNTech Covid-19 vaccine to children age…
Israel will roll out a booster dose of the Pfizer-BioNTech COVID-19 vaccine to older people, citing a drop in protection against severe disease driven by the Delta variant
Israeli health officials said they'd seen protection against severe illness from Pfizer's vaccine d…
Andrew Dunn
8 weeks between shots is the 'sweet spot' for giving Pfizer's two-dose COVID-19 vaccine, UK researchers say
It's not yet clear how changes in immune response relate to the protection you get from Pfizer's CO…